VYNE Therapeutics Declares Estimated $0.38-Per-Share Special Cash Dividend Ahead of Yarrow Merger
() -- VYNE Therapeutics (VYNE) on Friday declared a special cash dividend estimated at $16.5 million, or about $0.38 per share, in connection with its pending merger with Yarrow Bioscience. The dividend will be payable to shareholders and warrant holders of record as of July 22, with funds expected to be paid to VYNE's